These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 464094)

  • 21. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
    Meier JJ; Gallwitz B; Askenas M; Vollmer K; Deacon CF; Holst JJ; Schmidt WE; Nauck MA
    Diabetologia; 2005 Sep; 48(9):1872-81. PubMed ID: 16010522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
    J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of amino acids and gastric inhibitory polypeptide on insulin release in dogs.
    Yovos JG; O'Dorisio TM; Pappas TN; Cataland S; Thomas FB; Mekhjian H; Carey LC
    Am J Physiol; 1982 Jan; 242(1):E53-8. PubMed ID: 7036753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight.
    Schou JH; Pilgaard K; Vilsbøll T; Jensen CB; Deacon CF; Holst JJ; Vølund A; Madsbad S; Vaag AA
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4912-9. PubMed ID: 15899957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The priming effect of glucose on the gastric inhibitory polypeptide-induced insulin release.
    Jorde R; Amland PF; Burhol PG
    Scand J Gastroenterol; 1986 Jan; 21(1):47-50. PubMed ID: 3513294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
    Nauck M; Schmidt WE; Ebert R; Strietzel J; Cantor P; Hoffmann G; Creutzfeldt W
    J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day.
    Orskov C; Wettergren A; Holst JJ
    Scand J Gastroenterol; 1996 Jul; 31(7):665-70. PubMed ID: 8819215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of a 34-h fast on the meal-induced rises in plasma GIP, serum insulin, and blood glucose in man.
    Jorde R; Burhol PG; Schulz TB; Waldum HL; Lygren I; Jenssen T; Myhre ES
    Scand J Gastroenterol; 1981; 16(1):109-12. PubMed ID: 7015476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct effect of insulin on secretion of insulin, glucagon, gastric inhibitory polypeptide, and gastrin during maintenance of normoglycemia.
    Service FJ; Nelson RL; Rubenstein AH; Go VL
    J Clin Endocrinol Metab; 1978 Sep; 47(3):488-93. PubMed ID: 400722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of gastrointestinally derived peptides on concentrations of plasma insulin in sheep.
    Faulkner A
    Biochem Soc Trans; 1990 Dec; 18(6):1243-4. PubMed ID: 2088892
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males.
    Heruc GA; Horowitz M; Deacon CF; Feinle-Bisset C; Rayner CK; Luscombe-Marsh N; Little TJ
    Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E830-7. PubMed ID: 25231186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose-dependent insulinotropic polypeptide: blood glucose stabilizing effects in patients with type 2 diabetes.
    Christensen MB; Calanna S; Holst JJ; Vilsbøll T; Knop FK
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E418-26. PubMed ID: 24423311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cephalic phase secretion of insulin and other enteropancreatic hormones in humans.
    Veedfald S; Plamboeck A; Deacon CF; Hartmann B; Knop FK; Vilsbøll T; Holst JJ
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G43-51. PubMed ID: 26492921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of gastric inhibitory polypeptide on leucine- and arginine-stimulated insulin release.
    Mazzaferri EL; Ciofalo L; Waters LA; Starich GH; Groshong JC; DePalma L
    Am J Physiol; 1983 Aug; 245(2):E114-20. PubMed ID: 6349379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of gut hormone on insulin and glucagon secretion].
    Ohneda A; Ketterer H; Eisentraut AM; Unger RH
    Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():191-203. PubMed ID: 4907220
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice.
    Parker JC; Lavery KS; Irwin N; Green BD; Greer B; Harriott P; O'Harte FP; Gault VA; Flatt PR
    J Endocrinol; 2006 Oct; 191(1):93-100. PubMed ID: 17065392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interrelationships among insulin, glucagon, and gastric inhibitory polypeptide in insulinoma.
    Nelson RL; Service FJ; Go VL
    Mayo Clin Proc; 1980 Mar; 55(3):138-45. PubMed ID: 6243728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric inhibitory polypeptide, insulin, and glucose changes produced by growth hormone, prednisolone, glucagon, insulin, fasting, or diazoxide.
    Williams RH
    Proc Soc Exp Biol Med; 1979 Oct; 162(1):157-62. PubMed ID: 504226
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of actions of glucagon in adipocytes by gastric inhibitory polypeptide.
    Dupre J; Greenidge N; McDonald TJ; Ross SA; Rubinstein D
    Metabolism; 1976 Nov; 25(11):1197-9. PubMed ID: 185484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.